International cooperation on therapeutic products

Swissmedic authorises a new active substance (NAS) under the ACSS Consortium initiative for the first time


Out-of-Stock – Willfact, Injektionspräparat

Befristete Bewilligung zum Vertrieb in französischer Aufmachung


Chargenrückruf – Clavubactin ad us. vet., Tabletten

Chargenrückruf aufgrund von nicht konformen Resultaten in der Stabilitätsstudie bis auf Stufe Detailhandel


Out-of-Stock – Imaverol ad us. vet., Emulsionskonzentrat

Befristete Bewilligung zum Vertrieb in finnischer Aufmachung


Batch recall – Deaftol Mundspray, Lösung

Die im Firmenschreiben erwähnten Chargen bis auf Stufe Patient

In focus

Medical devices
New EU regulations (MDR, IVDR)

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

Direct links

Stay up to date

Incident reporting


Reporting undesirable effects

Medical devices

Reporting incidents & FSCAs




Therapeutic Products Legislation update

The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019


What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.

Swissmedic, Swiss Agency for Therapeutic Products


Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...